New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity (Q26823090)

main subject

anti-lymphocyte globulin

1 reference

stem cell transplantation

18 October 2019

1 reference

15 October 2020

immunosuppressive drug

1 reference

26 October 2020

1 reference

24 June 2021

1 reference

6 October 2019

6

Yvon Lebranchu

0 references

author name string

Mohamad Mohty

1

1 reference

Andrea Bacigalupo

2

1 reference

Faouzi Saliba

3

1 reference

Andreas Zuckermann

4

1 reference

Emmanuel Morelon

5

1 reference

language of work or name

1 reference

September 2014

1 reference

1 September 2014

8 references

25 June 2019

6 October 2019

18 October 2019

27 November 2019

13 December 2019

15 October 2020

26 October 2020

24 June 2021

9 references

25 June 2019

6 October 2019

18 October 2019

27 November 2019

13 December 2019

15 October 2020

26 October 2020

24 June 2021

74

1 reference

issue

14

1 reference

page(s)

1605-34

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

copyright license

1 reference

Europe PubMed Central

Induction therapy in heart transplantation: where are we now?

24 June 2021

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Vascularized composite tissue allotransplantation--state of the art

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Graft-versus-host disease after intestinal and multivisceral transplantation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Risk factors for impaired CD4 T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Pretransplant identification of acute rejection risk following kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Thymoglobulin and its use in renal transplantation: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Altering the course of type 1 diabetes: an update on prevention and new-onset clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Induction therapy in lung transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Management of acquired aplastic anemia in children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Donor-specific antibodies adversely affect kidney allograft outcomes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

The role of Thymoglobulin induction in kidney transplantation: an update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Intestinal and multivisceral transplantation immunosuppression protocols--literature review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Review article: use of induction therapy in liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Immunological issues in clinical composite tissue allotransplantation: where do we stand today?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Islet transplantation in type I diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Alemtuzumab as compared to alternative contemporary induction regimens.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Final results of the phase II study of rabbit anti‐thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony‐stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Bronchiolitis obliterans syndrome: the final frontier for lung transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A review of bronchiolitis obliterans syndrome and therapeutic strategies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Rabbit ATG for aplastic anaemia treatment: a backward step?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

The current trend of induction and maintenance treatment in patient of different PRA levels: a report on OPTN/UNOS Kidney Transplant Registry data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Alemtuzumab Induction in Renal Transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Update on infectious complications following lung transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

The decade of polyomavirus BK-associated nephropathy: state of affairs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Infectious complications of antilymphocyte therapies in solid organ transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Cardiac allograft vasculopathy: recent developments

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Tolerance and chimerism after renal and hematopoietic-cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

HLA-mismatched renal transplantation without maintenance immunosuppression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of action

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

First human face allograft: early report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Initial immunosuppression in liver transplant recipients with impaired renal function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Lymphoproliferative disease after renal transplantation in Australia and New Zealand

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Tolerogenic immunosuppression for organ transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Efficacy and Safety of Thymoglobulin Induction as an Alternative Approach for Steroid-Free Maintenance Immunosuppression in Pediatric Renal Transplantation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Rapid discontinuation of prednisone in higher-risk kidney transplant recipients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Comparison of polyclonal induction agents in pediatric renal transplantation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial.

31 May 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Prednisone-free maintenance immunosuppression-a 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Short-term experience with early steroid withdrawal in African-American renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Low-Dose Thymoglobulin Use in Elderly Renal Transplant Recipients Is Safe and Effective Induction Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3 lymphocyte counts in kidney and kidney-pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Retreatment by antithymocyte globulin for second kidney transplantation: efficacy, tolerance and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Complement-binding anti-HLA antibodies and kidney-allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

The influence of induction therapy on graft and patient survival in patients with and without hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Antithymocyte globulin induction therapy in hepatitis C-positive liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Induction immunosuppression with basiliximab in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Very early steroid withdrawal in simultaneous pancreas-kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Multicenter Australian trial of islet transplantation: improving accessibility and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Full face transplant: the first case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Human hand allograft: report on first 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Atypical acute rejection after hand transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Infection and malignancy after pediatric heart transplantation: the role of induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Acute rejection, T-cell-depleting antibodies, and cancer after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Risk factors for BK virus infection in the era of therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

A revised day 7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day 5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6-Month Course of Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Rabbit Anti-thymocyte Globulin Induction Therapy Does Not Prolong Survival After Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40265-014-0277-6

Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Hematologic adverse effects of 2 different polyclonal antilymphocyte preparations in de novo kidney transplant patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180909

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

28 November 2018

1 reference

12 December 2020

Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study

1 reference

12 December 2020

Single center experience with thymoglobulin in renal transplantation

1 reference

12 December 2020

Comparison of long-term effect of thymoglobulin treatment in patients with a high risk of delayed graft function

1 reference

12 December 2020

Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells

1 reference

12 December 2020

Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression

1 reference

12 December 2020

Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study

1 reference

12 December 2020

Protective conditioning for acute graft-versus-host disease

1 reference

12 December 2020

Thymoglobulin Versus Basiliximab Induction Therapy for Simultaneous Kidney-Pancreas Transplantation: Impact on Rejection, Graft Function, and Long-Term Outcome

1 reference

12 December 2020

T-cell-depleting antibodies and risk of cancer after transplantation

1 reference

12 December 2020

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis

1 reference

12 December 2020

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

12 December 2020

Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury

1 reference

12 December 2020

Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience

1 reference

12 December 2020

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

12 December 2020

A CD3 count-based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in kidney transplantation

1 reference

12 December 2020

Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial

1 reference

12 December 2020

Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model

1 reference

12 December 2020

Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal

1 reference

12 December 2020

Single-dose thymoglobulin induction in living-donor renal transplantation

1 reference

12 December 2020

Calcineurin inhibitor-free monotherapy in human leukocyte antigen–identical live donor renal transplantation

1 reference

12 December 2020

Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation

1 reference

12 December 2020

Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin

1 reference

12 December 2020

Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab

1 reference

12 December 2020

Outcome and cost analysis of induction immunosuppression with IL2Mab or ATG in DCD kidney transplants

1 reference

12 December 2020

The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients

1 reference

12 December 2020

Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients

1 reference

12 December 2020

Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation

1 reference

12 December 2020

Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients

1 reference

12 December 2020

Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation

1 reference

12 December 2020

Effects of Antibody Induction on Transplant Outcomes in Human Leukocyte Antigen Zero-Mismatch Deceased Donor Kidney Recipients

1 reference

12 December 2020

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

1 reference

12 December 2020

Antithymocyte globulin induction therapy in heart transplantation: prospective randomized study of high vs standard dosage

1 reference

12 December 2020

CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications

1 reference

12 December 2020

Obesity in Renal Transplantation: The Role of Induction Therapy on Long-Term Outcomes

1 reference

12 December 2020

Five years' experience with thymoglobulin induction in a pediatric renal transplant population.

1 reference

12 December 2020

Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation

1 reference

12 December 2020

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients

1 reference

12 December 2020

Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection

1 reference

12 December 2020

In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT

1 reference

12 December 2020

Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes

1 reference

12 December 2020

First human face transplantation: 5 years outcomes

1 reference

12 December 2020

Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation

1 reference

12 December 2020

Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft

1 reference

12 December 2020

Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party

1 reference

12 December 2020

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

1 reference

12 December 2020

Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation

1 reference

12 December 2020

A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients

1 reference

12 December 2020

Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy

1 reference

12 December 2020

Short course induction immunosuppression with thymoglobulin for renal transplant recipients

1 reference

12 December 2020

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day 7 after alternative donor transplants

1 reference

12 December 2020

Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid

1 reference

12 December 2020

10.1007/S40265-014-0277-6

Identifiers

DOI

1 reference

Dimensions Publication ID

1004051236

0 references

Fatcat ID

release_ffdaebzctjg5xfo575oj4v5shq

0 references

1 reference

1 reference

PubMed publication ID

25164240

1 reference